Urge Urinary Incontinence
28
4
4
13
Key Insights
Highlights
Success Rate
76% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
4 terminated out of 28 trials
76.5%
-10.1% vs benchmark
25%
7 trials in Phase 3/4
38%
5 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 13 completed trials
Clinical Trials (28)
High Intensity Magnetic Stimulation on Urge Urinary Incontinence in Postmenopausal Women
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)
COMPARATIVE EFFICACY OF ELECTROMAGNETIC FIELD THERAPY AND TIBIAL NERVE STIMULATION IN URGE URINARY INCONTINENCE
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy
Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin
SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE
Pelvic Floor Muscle Training With Leva System for Urge Incontinence
Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)
Incontinence & Intimate Partners: Assessing the Contribution of Treatment
Anticholinergic vs. Botox Comparison Study
Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
Further Enhancing Non-pharmacologic Therapy for Incontinence
Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder
A Comparison of Electrical Pudendal Nerve Stimulation and Transvaginal Electrical Stimulation for Urge Incontinence
Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments
Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence
Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women